Global Veterinary Antimicrobial Susceptibility Testing Market Segmentation, By Product Type (Disks and Plates, Culture Media, Accessories and Consumables, and Automated Antimicrobial Susceptibility Testing Instruments), Animal Type (Food-producing Animals and Companion Animals), End User (Veterinary Reference Laboratory, Veterinary Research Institutes and Universities, and Other) – Industry Trends and Forecast to 2031
Veterinary Antimicrobial Susceptibility Testing Market Analysis
The veterinary antimicrobial susceptibility testing market is witnessing significant growth, driven by the increasing prevalence of infectious diseases in both food-producing and companion animals, alongside heightened awareness regarding antibiotic resistance. As veterinarians and pet owners become more conscious of the need for effective and responsible antibiotic use, there is a growing demand for precise testing methods that can guide treatment decisions. Technological advancements, such as the development of automated testing instruments and rapid testing solutions, are enhancing the efficiency and accuracy of antimicrobial susceptibility testing. Furthermore, regulatory support and initiatives aimed at promoting responsible antibiotic use in veterinary medicine are bolstering market growth. With a diverse range of end-users, including veterinary reference laboratories, research institutes, and clinics, the market is expected to expand as more innovative testing solutions are introduced, addressing the critical need for effective management of infectious diseases in animals.
Veterinary Antimicrobial Susceptibility Testing Market Size
The global veterinary antimicrobial susceptibility testing market size was valued at USD 39.61 billion in 2023 and is projected to reach USD 59.60 billion by 2031, with a CAGR of 5.24% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Veterinary Antimicrobial Susceptibility Testing Market Trends
“Growing Emphasis on Antibiotic Stewardship”
The veterinary antimicrobial susceptibility testing market is experiencing substantial growth due to rising concerns over antibiotic resistance and the increasing incidence of infectious diseases in both companion and food-producing animals. One significant trend in the market is the growing emphasis on antibiotic stewardship, which encourages responsible antibiotic usage in veterinary practices. As veterinarians strive to optimize treatment outcomes while minimizing the risk of resistance, the demand for precise antimicrobial susceptibility testing is on the rise. In addition, advancements in rapid testing technologies and molecular diagnostics are enhancing the speed and accuracy of these tests, further driving market growth. Overall, the veterinary antimicrobial susceptibility testing market is poised for continued expansion as innovations in testing methods and a focus on stewardship reshape the landscape of veterinary care.
Report Scope and Veterinary Antimicrobial Susceptibility Testing Market Segmentation
|
Attributes
|
Veterinary Antimicrobial Susceptibility Testing Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
BD (U.S.), Synbiosis (U.S.), Zhuhai DL Biotech Co., Ltd. (China), Mast Group Ltd. (U.K.), HiMedia Laboratories (India), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Genefluidics, Inc. (U.S.), ROSCO DIOGNISTICA (Germany), Erba Mannheim (U.S.), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Italy), MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany), BIOMÉRIEUX (France), Merck KGaA (U.S.), Danaher (U.S.), Accelerate Diagnostics, Inc. (U.S.), NuMedii, Inc. (U.S.), and BacterioScan (U.S.)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Veterinary Antimicrobial Susceptibility Testing Market Definition
Veterinary Antimicrobial Susceptibility Testing (VAST) refers to a laboratory procedure used to determine the effectiveness of antimicrobial agents against specific bacteria or pathogens isolated from animals. This testing helps veterinarians identify which antibiotics or antimicrobial drugs are most effective in treating infections in animals, ensuring appropriate treatment choices that can improve animal health and reduce the risk of antibiotic resistance. VAST plays a critical role in veterinary medicine, particularly in managing infectious diseases, guiding treatment protocols, and promoting responsible use of antimicrobials in animal husbandry.
Veterinary Antimicrobial Susceptibility Testing Market Dynamics
Drivers
- Rising Prevalence of Antimicrobial Resistance
The rising prevalence of antimicrobial resistance (AMR) in animals is a critical market driver for the veterinary antimicrobial susceptibility testing (AST) sector. AMR poses a serious threat to animal health and welfare and undermines the effectiveness of antimicrobial treatments, leading to prolonged illness and increased mortality rates among livestock and pets. Veterinary antimicrobial susceptibility testing plays a vital role in this context by identifying the most effective antimicrobial agents for treating infections, thus helping to combat the challenge of AMR. By using AST, veterinarians can tailor treatment plans to ensure the selection of appropriate antimicrobials, improving treatment outcomes and minimizing the risk of resistance development. Such growing recognition of the importance of AST in managing AMR is driving demand in the veterinary sector, thereby significantly contributing to the expansion of the veterinary antimicrobial susceptibility testing market.
- Increasing Incidence of Infectious Diseases
The increasing incidence of infectious diseases among both companion and food-producing animals is a major driver of the veterinary antimicrobial susceptibility testing market. As outbreaks of infections such as canine parvovirus and feline leukemia become more common, veterinarians are faced with the challenge of effectively diagnosing and treating these diseases. For instance, a report from the American Veterinary Medical Association indicated that there has been a noticeable rise in antibiotic-resistant bacterial infections in livestock, necessitating the use of precise antimicrobial susceptibility testing to identify effective treatment options. This growing prevalence of infectious diseases heightens the demand for accurate testing and underscores the importance of tailored therapeutic approaches in veterinary medicine. As a result, the urgency to manage these infectious diseases effectively is propelling the market for antimicrobial susceptibility testing solutions, reinforcing the need for advanced diagnostic tools in veterinary practices.
Opportunities
- Increasing Adoption of Point-of-Care Testing
Point-of-care testing (POCT) involves performing diagnostic tests and obtaining results in real-time at the site of patient care. The adoption of POCT in veterinary medicine is on the rise, presenting a significant opportunity for the development of portable and user-friendly antimicrobial susceptibility testing devices that can be utilized directly in veterinary clinics or in the field. These rapid testing solutions offer immediate results, enabling veterinarians to make prompt treatment decisions based on the specific antimicrobial resistance patterns of the pathogens involved. This capability enhances the quality of care provided to animals and contributes to more effective disease management and better patient outcomes. By facilitating timely interventions, POCT can play a crucial role in improving overall animal health and welfare.
- Expansion of Veterinary Reference Laboratories
Veterinary reference laboratories are essential in delivering specialized diagnostic services, particularly antimicrobial susceptibility testing, to veterinary clinics and hospitals. As the demand for precise and comprehensive diagnostic testing rises, these laboratories have a significant opportunity for expansion. By investing in advanced testing technologies, such as automated systems and molecular diagnostics, veterinary reference labs can enhance their efficiency and accuracy in diagnosing infections. In addition, expanding their testing capacities enables them to accommodate a larger volume of samples and offer a broader array of antimicrobial susceptibility testing services. Such strategic growth helps meet the increasing market demand and supports veterinarians in making informed treatment decisions, ultimately improving animal health outcomes and promoting responsible antibiotic use in veterinary medicine.
Restraints/Challenges
- High Costs of Antimicrobial Susceptibility Testing
The high costs associated with antimicrobial susceptibility testing represent a significant barrier for veterinary clinics, particularly in developing regions where budget constraints restrict access to advanced diagnostics. Many veterinary practices, especially smaller clinics, may find it challenging to invest in the necessary testing equipment and reagents, which can be prohibitively expensive. This financial hurdle can lead to a reliance on traditional treatment methods without the benefit of tailored antimicrobial therapy, potentially resulting in ineffective treatment outcomes and contributing to the rise of antimicrobial resistance. As a consequence, the lack of affordable testing options limits the overall adoption of antimicrobial susceptibility testing in veterinary medicine. This challenge hampers market growth, as the inability to conduct effective testing may undermine efforts to improve animal health and welfare.
- Stringent Regulatory Standards
The veterinary antimicrobial susceptibility testing market encounters significant regulatory hurdles that can impede the approval and commercialization of new diagnostic products. Stringent regulatory requirements often necessitate extensive clinical trials and comprehensive documentation to demonstrate the safety and efficacy of testing devices and procedures. These lengthy processes can delay the introduction of innovative solutions into the market, which is critical for addressing emerging challenges related to antimicrobial resistance in veterinary medicine. Furthermore, navigating the complex landscape of regulations across different countries can be daunting for companies, especially smaller firms lacking the resources to manage compliance effectively. As a result, these regulatory challenges can hinder the timely availability of advanced diagnostic tools, limiting the market's growth and reducing veterinarians' ability to implement effective antimicrobial stewardship practices.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Veterinary Antimicrobial Susceptibility Testing Market Scope
The market is segmented on the basis of product type, animal type, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Disks and Plates
- Culture Media
- Accessories and Consumables
- Automated Antimicrobial Susceptibility Testing Instruments
Animal Type
- Food-producing Animals
- Cattle
- Poultry
- Pigs
- Others (Sheep, Goats, Veal)
- Companion Animals
- Dogs
- Cats
- Horses
- Others (Birds, Fish, Turtles)
End User
- Veterinary Reference Laboratory
- Veterinary Research Institutes and Universities
- Others
Veterinary Antimicrobial Susceptibility Testing Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, product type, animal type, and end-user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America leads the global veterinary antimicrobial susceptibility testing market due to its robust and advanced healthcare infrastructure, particularly in veterinary care. The region is equipped with an extensive network of veterinary clinics, diagnostic laboratories, and research institutions, all of which possess the resources and expertise required to conduct antimicrobial susceptibility testing effectively.
Asia-Pacific region is anticipated to experience significant growth from 2024 to 2031, driven by its large and expanding population that is increasingly demanding animal protein, such as meat, milk, and eggs. The intensification of animal production systems and the higher density of livestock can lead to the spread of infectious diseases and antimicrobial resistance. Consequently, there is an escalating need for effective diagnostics, including antimicrobial susceptibility testing, to safeguard the health and productivity of livestock and aquaculture.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Veterinary Antimicrobial Susceptibility Testing Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Veterinary Antimicrobial Susceptibility Testing Market Leaders Operating in the Market Are:
- BD (U.S.)
- Synbiosis (U.S.)
- Zhuhai DL Biotech Co., Ltd. (China)
- Mast Group Ltd. (U.K.)
- HiMedia Laboratories (India)
- Thermo Fisher Scientific Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Creative Diagnostics (U.S.)
- Genefluidics, Inc. (U.S.)
- ROSCO DIOGNISTICA (Germany)
- Erba Mannheim (U.S.)
- Liofilchem S.r.l. (Italy)
- Alifax S.r.l. (Italy)
- MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)
- BIOMÉRIEUX (France)
- Merck KGaA (U.S.)
- Danaher (U.S.)
- Accelerate Diagnostics, Inc. (U.S.)
- NuMedii, Inc. (U.S.)
Latest Developments in Veterinary Antimicrobial Susceptibility Testing Market
- In June 2023, bioMérieux achieved a remarkable milestone by receiving nine IMV ServiceTrak clinical laboratory awards. These awards recognized the company’s excellence across several key segments, including Immunoassay, ID/AST, and Blood Culture, highlighting its commitment to delivering high-quality diagnostic solutions and reinforcing its leadership position in the clinical laboratory market
- In April 2023, Bio-Rad Laboratories, Inc. introduced the ID-Check Speciation Solution, a cutting-edge tool designed to determine the animal species origin of meat samples. This innovative solution is invaluable for food, feed, and environmental testing, ensuring accurate identification and enhancing food safety and traceability in the supply chain
- In October 2022, Bioguard Corporation achieved a significant milestone by receiving ISO 17025 accreditation for its animal health diagnostic center. This accreditation underscores the organization’s commitment to maintaining high standards in laboratory practices, ensuring that its diagnostic services meet international quality requirements and can be relied upon by veterinary professionals
- In August 2022, Becton, Dickinson and Company entered into a commercial collaboration agreement with Accelerate Diagnostics, Inc. This strategic partnership aims to enhance the distribution of Accelerate’s comprehensive portfolio of antibiotic resistance and susceptibility products, thereby improving access to advanced diagnostic tools that are crucial for effective infection management
- In June 2021, bioMérieux entered into a distribution agreement with Specific Diagnostics to distribute their REVEAL Rapid AST system across Europe. This partnership allows bioMérieux to expand its portfolio of antimicrobial susceptibility testing solutions, enhancing its ability to deliver rapid and accurate diagnostics to healthcare providers in the region
SKU-